导航化学疗法诱导的听力损失的遗传风险在Stria Vascularis中
Tara Lazetic1, Deanne Nixie R Miao2, Britt I Drögemöller2,3,4,5
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Clinical pharmacology and therapeutics
|December 5, 2025
概括
西斯普拉丁化疗可以通过损害内耳的血管 (SV) 来导致永久性听力损失. 了解SV的遗传变异可以预测和预防这种耳毒性.
科学领域:
- 耳毒性研究研究
- 内耳生物学 内耳生物学
- 化疗的副作用 化疗的副作用
背景情况:
- 已知西斯普拉丁化疗会导致永久性听力损失.
- 这种听力损失是由于血管 (SV) 损伤造成的,这是一种关键的内耳组织.
- 精确的SV损伤的分子机制和可靠的耳毒性预测仍然是一个重大挑战.
研究的目的:
- 为了探索基底的分子机制,西斯普拉丁诱导的血管损伤.
- 调查基因变异在血管的作用作为耳毒性风险因素.
- 突出多原子方法的进步,以改善基因测试和自身保护剂的开发.
主要方法:
- 关于西斯的耳毒性现有文献的综述.
- 分析证据,将血管的遗传变异与化疗副作用联系起来.
- 讨论多原子数据集成策略 (基因组学和转录组学).
主要成果:
- 静脉内的遗传变异被认为是西斯普拉丁诱导的听力损失的重要风险因素.
- 多原子方法在整合基因组和转录基因组数据方面表现有前途.
- 这些综合方法可能会导致更好地预测耳毒性.
结论:
- 了解血管的遗传因素对于破译西斯普拉丁诱导的听力损失至关重要.
- 创新的多原子策略为改进遗传风险评估提供了潜力.
- 未来的研究方向包括开发向性自身保护剂和针对化疗患者进行个性化基因测试.
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


